Summary & Overview
HCPCS J3420: Injection, Vitamin B-12 (Cyanocobalamin) up to 1000 mcg
HCPCS Level II code J3420 denotes the injectable formulation of vitamin B-12 (cyanocobalamin), dosed up to 1000 micrograms. This code is used when vitamin B-12 is administered by injection in outpatient settings such as physician offices, clinics, or infusion centers. Nationally, B-12 injections are commonly used for documented deficiency, malabsorption syndromes, certain neurologic conditions, and when oral replacement is inadequate or impractical.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for J3420, typical sites of service, and the most commonly associated billing scenarios. The publication provides benchmarks and payment context where available, highlights policy considerations and coverage patterns among major payers, and summarizes common coding and billing practices relevant to outpatient injectable therapies.
This summary is intended to clarify the clinical and billing purpose of J3420, outline payer coverage landscape, and point to the sections that detail reimbursement benchmarks, coding guidance, and administrative considerations for healthcare billing teams and policy analysts.
Billing Code Overview
HCPCS Level II code J3420 represents injection, vitamin B-12 cyanocobalamin, up to 1000 mcg. This service is an administration of cyanocobalamin (vitamin B-12) by injection for patients requiring replacement or supplementation of vitamin B-12.
-
Service type: Therapeutic injectable medication
-
Typical site of service: Office, clinic, outpatient infusion or injection center, or other outpatient care settings where injectable medications are administered
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult patient with documented vitamin B12 deficiency (for example due to pernicious anemia, malabsorption, or after gastric bypass) presenting to an outpatient clinic or infusion suite for vitamin B12 replacement. The clinician (primary care physician, internal medicine specialist, family medicine provider, endocrinologist, hematologist, or pharmacist under protocol) reviews recent laboratory results showing low serum vitamin B12 and documents indication, informed consent, and planned dose. A single intramuscular or subcutaneous injection of cyanocobalamin up to 1000 mcg is prepared. Vital signs are assessed, the injection site is cleaned, and the medication is administered by a licensed professional. The encounter note documents the medication given as J3420, lot number, route (IM or SC), dose, and any immediate reaction or tolerance. The patient is observed briefly for adverse reaction and instructed on follow-up dosing schedule (for example weekly until levels normalize, then monthly maintenance) and return precautions. Billing uses HCPCS Level II code J3420 for the drug; an appropriate E/M or visit CPT code may be reported separately if medically necessary and documented, and modifiers may be appended when required (for example to indicate a distinct procedural service or reason for reduced services). Typical sites of service are outpatient clinic, physician office, federally qualified health center, community health clinic, or outpatient infusion/medication administration area within a hospital setting.
Coding Specifications
| Modifier | Description | When to Use |
|---|